Colorectal cancer

Medical Journal of Australia

Volumn 169, Issue 9, 1998, Pages 493-498

  Prichard, Peter J ^a,b   Tjandra, Joe J ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b NONE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; FLUOROURACIL; FOLINIC ACID; LEVAMISOLE; NONSTEROID ANTIINFLAMMATORY AGENT; SELENIUM;

ADULT; AGED; CANCER PREVENTION; CANCER SCREENING; CLINICAL FEATURE; COLON POLYP; COLORECTAL CANCER; DIET; FAMILY HISTORY; FEMALE; GENETIC PREDISPOSITION; HUMAN; INCIDENCE; LIFESTYLE; MALE; METASTASIS; OCCULT BLOOD TEST; PATHOGENESIS; PRACTICE GUIDELINE; PROGNOSIS; RECTUM HEMORRHAGE; RECTUM POLYP; REVIEW; RISK FACTOR;

EID: 0032476588     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1998.tb123379.x     Document Type: Review

References (46)

1. Australian Health Technology Advisory Committee (AHTAC). Colorectal cancer screening. Canberra: Commonwealth Department of Health and Family Services, 1997.
2. Jelfs P, Coates M, Giles G. Cancer in Australia 1989-1990. Cancer Series Number 5. Australian Institute of Health and Welfare. Canberra: AGPS, 1996.
3. St John DJB, McDermott FT, Hopper JL, et al. Cancer risk in relatives of patients with common colorectal cancer. Ann Int Med 1993; 118: 785-790.
4. Fuchs CS, Giovannucci EL, Colditz GA, et al. A prospective study of family history and the risk of colorectal cancer. N Engl J Med 1994; 331: 1669-1674.
5. Winawer SJ, Zauber AG, Gerdes H, et al. Risk of colorectal cancer in the families of patients with adenomatous polyps. N Engl J Med 1996; 334: 82-87.
6. Vasen HFA, Mecklin JP, Kahn PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colon Cancer (ICG-HNPCC). Dis Colon Rectum 1991; 34: 424-425.
7. Bell JC, McCredie M, Coates MS, Armstrong BK. Trends in colorectal cancer incidence and mortality in New South Wales, 1973-1992. Med J Aust 1997; 166: 178-181.
8. Williams AR, Balasooriya BAW, Day DW. Polyps and cancer of the large bowel: an autopsy survey. Gut 1982; 123: 835-842.
9. Muto T, Bussey HJR, Morson BC. The evolution of cancer of the colon and rectum. Cancer 1975; 36: 2251-2270.
10. Atkin WS, Morson BC, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 1992; 326: 658-662.
11. Morson BC. The evolution of colorectal carcinoma. Clin Radiol 1984; 35: 425-431.
12. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal tumor development. N Engl J Med 1988; 319: 525-532.
13. Kune GA, Bannerman S, Watson LF. Attributable risk for diet, alcohol and family history in the Melbourne Colorectal Cancer Study. Nutr Cancer 1992; 18: 231-235.
14. Leonard-Jones JE, Melville DM, Morson BC, et al. Precancer and cancer in extensive ulcerative colitis. Findings among 401 patients over 22 years. Gut 1990; 31: 800-806.
15. Bulow S, Svendsen LB, Mellemgaard A. Metachranous colorectal carcinoma. Br J Surg 1990; 77: 502-505.
16. Willett WC, Stampfer MJ, Colditz GA, et al. Relation of meat, fat and fibre intake in the risk of colon cancer in a prospective study among women. N Engl J Med 1990; 323: 1664-1672.
17. MacLennan R, Macrae F, Bain C, et al. The Australian Polyp Prevention Project Randomised trial of intake of fat, fibre and betacarotene to prevent colorectal adenomas. J Natl Cancer Inst 1995; 87: 1760-1766.
18. Potter JD. Nutrition and colorectal cancer. Cancer Causes Control 1996; 8: 127-146.
19. Caygill CPJ, Charlett A, Hill MJ. Fat, fish, fish oil and cancer. Br J Cancer 1996; 74: 59-64.
20. Guidelines for the prevention, early detection and management of colorectal cancer, Draft 3 - 30 June 1998. Canberra; National Health and Medical Research Council, 1998.
21. Gerhardson de Verdier M, Hagman U, Peters RK, et al. Meat, cooking methods and colorectal cancer: a case-reference study in Stockholm. Int J Cancer 1991; 49: 520-525.
22. Kune GA. Causes and control of colorectal cancer: a model for cancer prevention. Boston: Kluwer, 1996.
23. Winawer SJ, St John DJ, Bond JH, et al. Prevention of colorectal cancer: guidelines based on new data. Bull WHO 1995; 73: 7-10.
24. Rhodes M, Bradburn DM. Overview of screening and management of familial adenomatous polyposis. Gut 1992; 33: 125-131.
25. Lynch HT, Smyrk T. Hereditary non-polyposis colorectal cancer (Lynch syndrome): an updated review. Cancer 1996; 76: 1149-1167.
26. Järvinen HJ. Epidemiology of familial adenomatous polyposis in Finland: impact of family screening on the colorectal cancer rate and survival. Gut 1992; 33: 357-360.
27. Clark LC, Combs GF, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. JAMA 1996; 276: 1957-1963.
28. Giovannucci E, Rimm EB, Stampfer MJ, et al. Aspirin use and the risk of colorectal cancer and adenoma in male health professionals. Ann Int Med 1994; 121: 241-246.
29. Giovannucci E, Egan KM, Hunter DJ, et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med 1995; 33: 609-614.
30. Goulston K, Cook I, Dent OF, et al. How important is rectal bleeding in the diagnosis of bowel cancer and polyps. Lancet 1986; 2: 261-265.
31. Rex DK, Rahmani EY, Haseman JH, et al. Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice. Gastroenterology 1997; 112: 17-23.
32. Muller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. Ann Int Med 1995; 123: 904-910.
33. Lieberman DA. Cost-effectiveness model for colon cancer screening. Gastraenterology 1995; 109: 1781-1790.
34. Hardcastle JD, Chamberlain JO, Robinson MHE, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996, 348: 1472-1477.
35. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348: 1467-1471.
36. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Eng J Med 1993; 328: 1365-1371.
37. Sinatra MA, Young GP, St John DJB, et al. A study of laboratory based faecal occult blood testing in Melbourne, Australia. J Gastroenterol Hepatol 1998; 13: 396-400.
38. Jorgensen OD, Kronborg O, Fenger C. A randomised surveillance study of patients with pedunculated and small sessile tubular and tubulovillous adenomas: the Funen Adenoma Follow-up Study. Scand J Gastroenterol 1995; 30: 686-692.
39. Connell WR, Lennard-Jones JE, Williams CB, et al. Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 1994; 107: 934-944.
40. Tjandra JJ. Surgery of colon carcinoma. Asian J Surg 1995; 18: 196-201.
41. Moertel CG, Fleming TR, MacDonald JS, et al. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Int Med 1995; 122: 321-326.
42. Francini G, Petrioli R, Lorenzini L, et al. Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer. Gastroenterology 1994; 106: 899-906.
43. Krook JE, Moertel CG, Gunderson LL, et al. Effective surgical adjuvant therapy for high risk rectal cancer. N Engl J Med 191; 324: 709-715.
44. Newland RC, Dent OF, Chapuis PH, Bokey L. Survival after curative resection of lymph node negative colorectal carcinoma. A prospective study of 910 patients. Cancer 1995; 76: 564-571.
45. Newland RC, Dent OF, Lyttle MN, et al. Pathologic determinants of survival associated with colorectal cancer with lymph node metastases. A multivariate analysis of 579 patients. Cancer 1994; 73: 2076-2082.
46. Newland RC, Dent OF, Chapuis PH, Bokey L. Clinicopathologically diagnosed residual tumour after resection for colorectal cancer. A 20-year prospective study. Cancer 1995; 76: 564-571.